Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BLUE will rise by +3.30% over the next 2 Weeks and hit $5.13 by Friday, June 13, 2025. In that time frame, BLUE's share price is expected to range between $4.53 and $5.76.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jun 13, 2025 | 4.31 | 4.95 | 5.61 |
| Jun 12, 2025 | 4.24 | 4.91 | 5.56 |
| Jun 11, 2025 | 4.19 | 4.84 | 5.48 |
| Jun 10, 2025 | 4.08 | 4.71 | 5.34 |
| Jun 9, 2025 | 3.98 | 4.64 | 5.37 |
| Jun 6, 2025 | 4.20 | 4.87 | 5.52 |
| Jun 5, 2025 | 4.19 | 4.83 | 5.48 |
| Jun 4, 2025 | 4.13 | 4.75 | 5.42 |
| Jun 3, 2025 | 3.97 | 4.63 | 5.31 |
| Jun 2, 2025 | 3.89 | 4.55 | 5.22 |
BLUE shares remained flat 0 in Monday, June 2, 2025's trading session, starting and closing at a previous close of $4.97 to move at $4.97. The stock demonstrated notable intraday movement (see BLUE's key stats for a full breakdown), fluctuating between $4.97 and $4.97, a 0 trading range. While recent weeks have seen some volatility, BLUE has managed to secure a 0 no change over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 1.23M shares changing hands, 537.6K more than the previous session. This amounted to $6.12M in total market activity.
Will BLUE Continue Its Upward Trend?
According to analyst ratings and projections for BLUE, bluebird bio, Inc. shares are anticipated to increase by +11.45%, potentially reaching $5.61 per share by June 13, 2025. Short-term technical indicators currently suggest a neutral sentiment for BLUE. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 10 positive trading days within the past 30 sessions. Based on the BLUE stock forecast, now is a good time to buy BLUE stock because its current trading price is +0.32% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BLUE covering social and institutional perspectives.
BLUE Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BLUE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 57.54% to 69.14%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 47.45%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 45.02%, maintains a neutral outlook for the long term. Insights into BLUE's shareholder base show how institutional investors are positioning themselves during these momentum shifts
bluebird bio, Inc. Monthly Forecast 2025–2026
July 2025
According to our latest forecast models, bluebird bio, Inc. (BLUE) is positioned to show a strong performance in July 2025. The price is predicted to move between $0.00 and $4.92, settling at an average of $2.08. This could translate to a -58.15% loss.
August 2025
Based on current market signals, bluebird bio, Inc. is projected to trend august 2025. We forecast a trading range from $0.00 to $5.02, with a likely average price of $1.89. Investors could expect a potential return of -61.97%.
September 2025
Our predictive algorithms indicate bluebird bio, Inc. stock may see a shift in September 2025. The expected range spans $0.00–$4.32, with an average target of $1.38. This represents a cautious outlook and a possible loss of -72.23%.
October 2025
Analyzing established trends, bluebird bio, Inc. looks set to move in October 2025. Projections place the stock between $0.00 and $4.35, averaging around $1.47. This suggests a -70.42% loss from current levels.
November 2025
Market indicators suggest bluebird bio, Inc. could experience notable changes during November 2025. Prices could fluctuate within $0.00 to $4.20, with a midpoint forecast of $1.29. The stock might deliver a -74.04% loss.
December 2025
Forecasting for December 2025, models estimate that bluebird bio, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $3.94, averaging $1.13. This signals a cautious trajectory with potential returns around -77.26%.
January 2026
According to our latest forecast models, bluebird bio, Inc. (BLUE) is positioned to show a strong performance in January 2026. The price is predicted to move between $0.00 and $3.37, settling at an average of $0.73. This could translate to a -85.31% loss.
February 2026
Based on current market signals, bluebird bio, Inc. is projected to trend february 2026. We forecast a trading range from $0.00 to $3.19, with a likely average price of $0.44. Investors could expect a potential return of -91.15%.
March 2026
Our predictive algorithms indicate bluebird bio, Inc. stock may see a shift in March 2026. The expected range spans $0.00–$3.45, with an average target of $0.46. This represents a cautious outlook and a possible loss of -90.74%.
April 2026
Analyzing established trends, bluebird bio, Inc. looks set to move in April 2026. Projections place the stock between $0.00 and $3.16, averaging around $0.28. This suggests a -94.37% loss from current levels.
May 2026
Market indicators suggest bluebird bio, Inc. could experience notable changes during May 2026. Prices could fluctuate within $0.00 to $3.25, with a midpoint forecast of $0.28. The stock might deliver a -94.37% loss.
BLUE's history of dividends and stock splits also plays a role in long-term investor confidence.